Endralazine
Basic information
- CAS
39715-02-1- Standard SMILES
NNc1cc2c(nn1)CCN(C(=O)c1ccccc1)C2- InChIKey
ALAXZYHFVBSJKZ-UHFFFAOYSA-N- Molecular formula
- C14H15N5O
- Average molar mass
- 269.3 g/mol
- Monoisotopic mass
- 269.12766012
Overview
Endralazine is a member of benzamides.
Names & identifiers
- Preferred name
- Endralazine
- IUPAC
- (3-hydrazinyl-7,8-dihydro-5H-pyrido[4,3-c]pyridazin-6-yl)-phenylmethanone
- English name
- ENDRALAZINE
- Molecular formula
- C14H15N5O
- Molecular weight
- 0
Names & synonyms
ENDRALAZINE39715-02-1EndralazinaEndralazinumDTXSID40192791L44741F05PRefChem:136810C02DB03DTXCID80115282(3Z)-6-benzoyl-3-hydrazinylidene-2H,3H,5H,6H,7H,8H-pyrido(4,3-c)pyridazineMiretilan(3-hydrazinyl-7,8-dihydro-5H-pyrido[4,3-c]pyridazin-6-yl)-phenylmethanone
Show more names
6-Benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido(4,3-C)pyridazin6-Benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine3-Hydrazino-5,6,7,8-tetrahydropyrido(4,3-C)pyridazin-6-yl-phenyl-keton
Endralazine (INN)ENDRALAZINE [INN]Endralazine [INN:BAN]Endralazinum [INN-Latin]BQ 22-708Endralazina [INN-Spanish]NSC310289Arritlan
Database identifiers
- CAS
39715-02-1- PubChem CID
- 47608
- DTXSID
DTXSID40192791- ChEMBL
CHEMBL254193- ChEBI
CHEBI:135105- UNII
- L44741F05P
- Nikkaji
- J16.544A
Properties
Computed structural properties
- XLogP
- 0.4
- Topological polar surface area
- 84.1 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 20
- Formal charge
- 0
- Complexity
- 344
Physicochemical properties
- Melting point
- 220 · 220-223° (dec)
- FDA UNII
- 44741 F05P · L44741F05P
- ATC code
- 2 DB03 · C02DB03
Chemistry & industry
Pharmacology
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Drugs used to cause dilation of the blood vessels.
Applications
Uses[endralazine]. Antihypertensive.
Upstream & downstream products
Upstream raw materials
Additional notes
DefinitionChEBI: Endralazine is a member of benzamides.
Suppliers
Loading…
Open inquiries
Loading…
Related reactions
16 records
Compound notes
Loading…